REQUEST A DEMO
Total
USD $0.00
Search more companies

Komtur Pharmaceuticals SRL (Romania)

Main Activities: Advertising Agencies
Full name: Komtur Pharmaceuticals SRL Profile Updated: April 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Komtur Pharmaceuticals SRL is an enterprise located in Romania, with the main office in MOGOSOAIA. It operates in the Advertising Agencies industry. It was established on November 08, 2017. 6 (2025) employees currently work for Komtur Pharmaceuticals SRL. From the latest financial highlights, Komtur Pharmaceuticals SRL reported a net sales revenue increase of 34.8% in 2025. Its’ total assets recorded a growth of 18.63%. The net profit margin of Komtur Pharmaceuticals SRL increased by 0.65% in 2025.

Headquarters
Strada Turmelor Nr. 1a
MOGOSOAIA; Ilfov; Postal Code: 077135

Contact Details: Purchase the Komtur Pharmaceuticals SRL report to view the information.

Basic Information
Total Employees:
Purchase the Komtur Pharmaceuticals SRL report to view the information.
Registered Capital:
Purchase the Komtur Pharmaceuticals SRL report to view the information.
Financial Auditors:
Purchase the Komtur Pharmaceuticals SRL report to view the information.
Incorporation Date:
November 08, 2017
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Komtur Pharmaceuticals SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
34.8%
Total Operating Revenue
34.8%
Operating Profit
44.76%
EBITDA
53.87%
Net Profit/Loss for the Period
46.29%
Total Assets
18.63%
Total Equity
71.98%
Operating Profit Margin
0.66%
Net Profit Margin
0.65%
Return on Equity (ROE)
-7.35%
Quick Ratio
0.26%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?